Drug intelligence / Profile preview

Shenggui Oral Liquid

Development stage
Unknown
Lead developer
Monyan Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Shenggui Oral Liquid is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Chongqing Sainuo Biological Pharmaceutical. It is primarily indicated for the treatment of the common cold (specifically the Qi-deficiency type), chronic rhinitis, and allergic rhinitis. The preparation is based on a combination of classic TCM formulas, notably Guizhi Tang (Cinnamon Twig Decoction) and Yu Ping Feng San (Jade Windscreen Powder), which are traditionally used to strengthen the body's defensive energy and expel external pathogens. Pharmacologically, the active components from herbs such as *Astragalus membranaceus* and *Cinnamomum cassia* exhibit immunomodulatory, anti-inflammatory, and anti-allergic properties, helping to reduce nasal mucosal edema and alleviate systemic symptoms like fatigue and aversion to cold. It is an approved pharmaceutical product in China (NMPA approval number Z20025088).

Brand names
生桂
Other names
Shenggui Koufuye生桂口服液

Beyond the preview

Go deeper on Shenggui Oral Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenggui Oral Liquid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call